UK markets closed

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
361.48+5.86 (+1.65%)
At close: 04:00PM EDT
357.17 -4.31 (-1.19%)
After hours: 05:26PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 27.89B
Enterprise value 28.97B
Trailing P/E 38.97
Forward P/E 37.74
PEG ratio (5-yr expected) 4.60
Price/sales (ttm)8.74
Price/book (mrq)43.60
Enterprise value/revenue 8.85
Enterprise value/EBITDA 27.88

Trading information

Stock price history

Beta (5Y monthly) 1.11
52-week change 3-42.79%
S&P500 52-week change 3-8.83%
52-week high 3706.95
52-week low 3318.50
50-day moving average 3391.47
200-day moving average 3536.02

Share statistics

Avg vol (3-month) 3697.97k
Avg vol (10-day) 3772k
Shares outstanding 584.01M
Implied shares outstanding 6N/A
Float 883.17M
% held by insiders 10.94%
% held by institutions 189.19%
Shares short (30 May 2022) 41.81M
Short ratio (30 May 2022) 41.92
Short % of float (30 May 2022) 42.44%
Short % of shares outstanding (30 May 2022) 42.16%
Shares short (prior month 28 Apr 2022) 41.24M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 315 Jun 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 22.43%
Operating margin (ttm)28.49%

Management effectiveness

Return on assets (ttm)23.70%
Return on equity (ttm)109.37%

Income statement

Revenue (ttm)3.27B
Revenue per share (ttm)38.56
Quarterly revenue growth (yoy)7.60%
Gross profit (ttm)1.89B
Net income avi to common (ttm)734.55M
Diluted EPS (ttm)8.52
Quarterly earnings growth (yoy)-5.00%

Balance sheet

Total cash (mrq)204.62M
Total cash per share (mrq)2.44
Total debt (mrq)1.28B
Total debt/equity (mrq)200.62
Current ratio (mrq)1.12
Book value per share (mrq)7.60

Cash flow statement

Operating cash flow (ttm)745.83M
Levered free cash flow (ttm)504.06M